RPTX - Repare Therapeutics Inc
2.65
0.020 0.755%
Share volume: 1,219,919
Last Updated: 01-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.63
0.02
0.01%
Summary score
41%
Profitability
47%
Dept financing
21%
Liquidity
58%
Performance
36%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-6.12%
Return on assets
-8.38%
Return on sales
-1734.71%
Return on invested capital
59.13%
Total debt ratio
18.43%
Debt ratio change over timeo
-0.8%
Current Ratio
7.06%
Quick Ratio
6.72%
Cash Position Ratio
5.56%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-12.71%
Return on sales
9.73%
Return on invested capital
0%
Total debt ratio
12.23%
Debt ratio change over timeo
0%
Current Ratio
8.3%
Quick Ratio
0%
Cash Position Ratio
4.69%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0.93%
Return on sales
9.73%
Return on invested capital
0%
Total debt ratio
9.17%
Debt ratio change over time
0%
Current Ratio
10.71%
Quick Ratio
0%
Cash Position Ratio
6.27%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108.86%
Return on assets
-106.73%
Return on sales
-1056.78%
Return on invested capital
-38.4%
Total debt ratio
-80.4%
Debt ratio change over time
-0.8%
Current Ratio
4.62%
Quick Ratio
6.41%
Cash Position Ratio
4.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RPTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -6.12% | 13.23% | 9.84% | 26.17% |
| Return on assets | -8.38% | 4.59% | 3.2% | 1.81% |
| Return on sales | -1734.71% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 59.13% | 8.51% | 10.28% | 4.83% |
| Profitability | 25% | 66% | 52% | 57% |
| Total debt ratio | 18.43% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | -0.8% | -16.59% | -73.52% | 21.11% |
| Dept financing | 5% | 22% | 16% | 50% |
| Current Ratio | 8.3% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 4.69% | 0.14% | 0.46% | 0.15% |
| Liquididy | 75% | 8% | 10% | 7% |
| Short-term ratios | RPTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -12.71% | 5.82% | 4.08% | 0.78% |
| Return on sales | 9.73% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 56% | 50% | 34% | 13% |
| Total debt ratio | 12.23% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 20% | 15% | 25% |
| Current Ratio | 8.3% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 4.69% | 0.14% | 0.46% | 0.15% |
| Liquididy | 50% | 30% | 26% | 17% |